Murine xenograft models likewise displayed higher tumor-to-background ratios on [68Ga]Ga-DOTATATE PET after everolimus, consistent with drug-induced SSTR2 gene upregulation (Zellmer et al., 2022). The gene discussed is SSTR2; the disease is neoplasm.